In this forum you’ll find threads with links to articles that you may pick for your “student selected article” to critique. You are welcome to pick an article that I have not listed. Just be sure that it is relevant to concepts covered in this module. Remember, you also need to comment on the critiques of at least two other students AND respond to a least two comments made by other students.
Mars 2020 Perseverance Landing Press Kit
Critique the information available at the following link, and relate it to what you have been learning about astrobiology and/or macromolecules that are important to building carbon-based life. Then, be sure to provide your reaction (insights, opinions, conclusions).
NASA. “Mars 2020 Perseverance Landing Press Kit | Introduction.” NASA/JPL, 2021, www.jpl.nasa.gov/news/press_kits/mars_2020/landing/.
“Mitochondrial oxidation linked to aging (Antioxidant Nutrients May Help)”Read, critique, and respond to the issue indicated for the article pasted below:
1) Use the “Critique Guidelines” to assist you with this assignment.
2) ISSUE: This article contains brief summaries of many research studies related to the topic. In your critique, describe the control group, experimental group(s), independent variable, and dependent variable for 2 of these studies. 3) Note that this article was published in 2003. In the reaction section, include at least a brief statement about whether you think that mitochondrial research has been a valuable avenue of study. (Hint: This statement will be easier to make if you are able to relate it to more recent mitochondrial research.)Sherman, Carl. “Mitochondrial oxidation linked to aging. (Antioxidant Nutrients May Help).” Clinical Psychiatry News 31.2 (Feb 2003): 51(1). InfoTrac OneFile. Thomson Gale. New Paltz University College
Full Text:COPYRIGHT 2003 International Medical News Group
NEW YORK — The cumulative impact of oxidative stress on mitochondrial DNA may be responsible for many age-associated changes, perhaps including neurodegenerative disorders, Dr. M. Flint Beal said at the annual meeting of the Association for Research in Nervous and Mental Disease.
Some evidence suggests that increased antioxidant dietary intake or supplementation could ameliorate the process and attenuate the risk of Alzheimer’s disease, said Dr. Beal, professor and chairman of neurology at Cornell University, New York.
The “oxidative stress theory of aging” maintains that cells are subject to a constant imbalance between damage caused by reactive oxygen species and the protection afforded by endogenous antioxidant and repair mechanisms. As the theory goes, such damage increases with age, and the process is responsible for physiologic and functional deficits of aging.
Mitochondria would appear to be a prime candidate site of damage: 85%-90% of cellular oxygen consumption occurs in these structures, and 1%-3% of the process produces reactive oxygen species. “It’s the Achilles’ heel of the cell,” Dr. Beal said.
A postmortem study of nuclear DNA From the cerebral cortex suggested a “dramatic effect of aging” on the mitochondria in particular. There was 50% more oxidative damage in the nuclear DNA of people over 70, compared with younger samples but a 15-fold increase in mitochondrial DNA, he said.
Dr. Michael Lin of the university reported supporting evidence of links between mitochondrial DNA damage, aging, and neurodegenerative disorders. Mitochondrial dysfunction caused by toxins can mimic parkinsonism and reproduce the symptoms of Huntington’s disease “with remarkable fidelity,” he said.
A study using “cybrid” cells, in which mitochondrial DNA from enucleated cells (platelets) is transferred into DNA-depleted cells, found declines in mitochondrial function when the donor cells were from older individuals, compared with younger people, and from patients with Parkinson’s disease and Alzheimer’s disease (AD), compared with healthy controls.
A comparison of brain cells from 17 subjects with AD (10 aged control subjects and 14 younger subjects) found a significant increase in mitochondrial DNA mutations in elderly, compared with younger, individuals, he said.
Dr. Beal reported evidence from animal and human studies to suggest that interventions to increase endogenous or external antioxidant activity might attenuate the ostensible consequences of oxidative damage. Genetic manipulation aimed at increasing production of antioxidant enzyme systems in animal models increased life span by 16%-70%, he said.
In research involving human populations, one study that followed more than 800 individuals, aged 65 and older, for a mean of 4 years found that those whose dietary intake of vitamin B fell into the highest quintile had a 64% reduction in AD risk, compared with those in the lowest quintile.
In another, which included 5,400 participants, increased dietary intake of vitamin B and C was associated with an AD risk reduction of 18% per standard deviation.
In the Cache County (Utah) aging study, vitamin E and C supplementation was associated with a relative risk of AD of 0.32.
Similar findings have been reported in relation to the course of Parkinson’s disease. One study randomized 120 patients to receive three doses of the antioxidant supplement coenzyme Q10, or placebo. Over a 16-month period, scores on an index of disease severity rose by 12 points in the placebo group, compared with 6.6 points at the highest dose (1,200 mg/day) of coenzyme Q10, he said.
Thomson Gale Document Number:A98315261
2005 Thomson Gale, a part of The Thomson Corporation. Thomson and Star Logo are trademarks and are registered trademarks used herein under license.”When Cells Stop Working”Read and critique the article pasted below. You may find writing your critique to be more interesting and easier for you, if you also include information you learn about a research finding about mitochondrial disease that was posted since this 2006 article.
Use the “Critique Guidelines” to assist you with this assignment.
Lemonick, Michael D. “When Cells Stop Working.(Science; Health)(mitochondrial disease).” Time 168.20 (Nov 13, 2006): 58. InfoTrac OneFile. Thomson Gale. New Paltz University College – SUNY.
Full Text:COPYRIGHT 2006 Time, Inc.
Byline: Michael D. Lemonick
Children keep dying from mysterious illnesses that have been traced to tiny structures called mitochondria
Nothing worries parents more than a sick infant–especially when nobody can figure out what’s wrong. For Asher Gould’s parents, the uncertainty lasted for the first three years of their son’s life. Asher’s older brother Sam, now 10, has always been pretty healthy. But a couple of months after he was born, Asher started having trouble feeding and was spotting his diapers with blood. The pediatrician decided he had an allergy to milk. Then, at 9 months, he couldn’t crawl or sit up. The diagnosis this time was hypotonia, a vague term that basically means “poor muscle tone.” With physical therapy, Asher walked at 17 months, but then a month later he caught a cold–and overnight lost half his vocabulary. Nobody could figure out what was going on.
Asher was almost 3 when he began preschool, and that’s when the phone started ringing. He was falling down at school. He became weaker and weaker. And after a mild flu, he stopped eating. By Christmas he was emaciated, but with a big, distended belly. His intestines had all but stopped working, and nobody could figure out why. Maybe it was myopathy (a muscle disease) or some sort of nerve-wasting disorder. “Don’t try to figure it out,” advised a doctor. “Just put in a feeding tube.”
But Asher’s parents–Anne Reckling, a child psychologist, and David Gould, an administrator at a private school in Columbus, Ohio–were determined to get to the bottom of it. On the urging of someone on a myopathy e-mail discussion list, they went to see Dr. John Shoffner, a neurologist and geneticist at Horizon Molecular Medicine, a private group in Atlanta. A few weeks later, a fax arrived with Shoffner’s diagnosis. Asher was suffering from a type of mitochondrial disease.
If the term is unfamiliar, that’s no surprise. “When I began working on mitochondrial disease back in the ’80s,” says Shoffner, “people were still arguing over whether it even existed.” Nobody is arguing about that anymore. In fact, doctors have now identified hundreds of different subtypes of the disorder. What they all have in common is a malfunction of the mitochondria–tiny substructures, or organelles, found inside every cell in the body. Their job is to convert food into a chemical called ATP that cells use for energy. When they go bad, all sorts of havoc is wreaked on the body. Depending on which types of cells are affected, mitochondrial disease can cause muscle wasting, nerve damage, seizures, stroke, blindness, deafness and more.
Officially, as many as 2 million Americans suffer from mitochondrial disease. But because defects in the mitochondria may underlie an astonishing range of very familiar illnesses, researchers are beginning to suspect that the real number is vastly higher. In the past few weeks alone, reports have come out in Cell, Nature and the Journal of Neuroscience implicating the mitochondria as factors in diseases such as Alzheimer’s and Parkinson’s. Indeed, says Dr. Vamsi Mootha, a Harvard Medical School researcher who won a MacArthur Foundation “genius” grant in 2004 for his work on mitochondria, “it looks like they’re really important in diabetes, hypertension and many other common diseases–even in the aging process itself.”
Exactly what role mitochondria play in these illnesses is still unclear. It’s not even certain whether mitochondrial breakdowns are the cause or the effect of disease–although researchers suspect it’s often a little of both. As mitochondria process food into energy, they create free radicals–highly reactive oxygen ions that can cause damage to proteins. Many experts believe that as cells age, this damage accumulates, weakening the mitochondria irrevocably and doing harm to specific organs–or, more generally, to the whole body. There’s no smoking gun yet, says Mootha, but there’s some tantalizing evidence. “We do know,” he says, “that exercise can help slow the damage from diabetes and other disorders and also that exercise boosts the function of mitochondria.”
In the known mitochondrial diseases, though, it’s clearly a genetic abnormality that almost always sets things off. Mitochondria are different from the rest of the cell in that they have their own DNA, inherited directly from the mother (with no input from the father) that’s entirely separate from the DNA in the nucleus. Evolutionary biologists suspect, in fact, that these organelles started out as independent bacteria that were absorbed long ago into cells and harnessed as energy factories.
By the mid-1980s, says Mootha, the mitochondrial genome–with only about 16,000 genetic “letters,” compared with 3 billion in the nuclear genome–had been sequenced. That let researchers link specific, rare disorders to specific mitochondrial mutations, always passed from mother to child. But by the time the Human Genome Project was completed in 2000, it was clear that mutations in the nucleus could cause problems in the mitochondria as well. “We now estimate,” says Mootha, “that while mitochondrial DNA encodes just 13 proteins, another 1,500 or so proteins used by mitochondria are encoded by the nucleus.”
This helps explains why mitochondrial disease occurs in such bewildering variety and why it can be so difficult to diagnose. Even now that it’s better understood, parents sometimes face doctors’ accusations of deliberately poisoning children to draw attention to themselves.
There’s no cure yet for mitochondrial disease, nor even a surefire treatment. Sufferers are usually given vitamin and nutritional supplements, which can help slow the progress of the illness, but they aren’t always effective. “If you’d asked me a year ago,” says Shoffner, “I would have said that’s the only option.” Since then, however, some promising drugs have been developed, and will soon go into clinical trials. And a new company called Edison Pharmaceuticals, of San Jose, Calif., was founded last year for the sole purpose of coming up with drugs for mitochondrial disease.
Still, supplements have made a big difference for Asher. He tires easily and has to conserve energy–he uses a wheelchair if he has to travel long distances. He still needs a feeding tube. And he has damage to his optic and auditory nerves, along with some cognitive impairment. Nevertheless, says his mother, “he’s a really positive, upbeat boy.” Now 5, Asher is in kindergarten. He takes karate lessons and is learning to play tennis. But his family is well aware that he may not survive childhood, so they’re always vigilant–sometimes to a fault. One morning last week, says Reckling, “he told me his legs were tingling. I don’t know if it’s new nerve damage–or if his feet were just asleep.”
Asher still needs a feeding tube, but he can play tennis and do karate
Thomson Gale Document Number:A153864743
2005 Thomson Gale, a part of The Thomson Corporation. Thomson and Star Logo are trademarks and are registered trademarks used herein under license.
